Not applicableStudy completedNCT05543564What this trial is testingProphylactic PRP in Moderate NPDRWho this might be right forEye DiseasesDiabetesDiabetic Retinopathy Assiut University 68
Not applicableStudy completedNCT04636307What this trial is testingCharacterization of Retinal Disease Progression in Eyes With Non Proliferative Diabetic Retinopathy in Diabetes Type 2 Using Non-invasive Procedures (CHART)Who this might be right forNPDR - Non Proliferative Diabetic RetinopathyDiabetes Mellitus, Type 2Retinal Disease Association for Innovation and Biomedical Research on Light and Image 202
Not applicableNot Yet RecruitingNCT05852132What this trial is testingClinical Study on Prognosis of Patients With Severe NPDR Undergoing VitrectomyWho this might be right forNon Proliferative Diabetic Retinopathy(NPDR) Fei Gao 249
Not applicableStudy completedNCT01145599What this trial is testingIdentifying Progression of Retinal Disease in Eyes With NPDR in Diabetes Type 2 Using Non-invasive ProceduresWho this might be right forType 2 DiabetesNon Proliferative Diabetic Retinopathy European Vision Institute Clinical Research Network 374
Very early researchNot Yet RecruitingNCT07198815What this trial is testingA Preliminary Exploratory Clinical Trial to Evaluate the Efficacy of NPDR-01 Eye Drops in the Treatment of Non-Proliferative Diabetic RetinopathyWho this might be right forNon-proliferative Diabetic Retinopathy (NPDR)Diabetic Retinal MicroangiopathyRetinal Microaneurysms+1 more Sichuan Academy of Medical Sciences 10
Large-scale testing (Phase 3)Study completedNCT02718326What this trial is testingStudy of the Efficacy and Safety of Intravitreal (IVT) Aflibercept for the Improvement of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy (NPDR)Who this might be right forNonproliferative Diabetic Retinopathy Regeneron Pharmaceuticals 402
Testing effectiveness (Phase 2)Looking for participantsNCT06770933What this trial is testingEvaluate the Efficacy and Safety of Orally Administered VX-01Who this might be right forDiabetic RetinopathyNPDR - Non Proliferative Diabetic Retinopathy Vantage Biosciences Ltd 100
Testing effectiveness (Phase 2)Study completedNCT06599684What this trial is testingStudy of INV-102 Ophthalmic Solution in Adults With Diabetic Macular Edema Associated With Non-proliferative Diabetic RetinopathyWho this might be right forNon-center Involved Diabetic Macular EdemaNon-center Involved Diabetic Macular Edema Associated With Non-proliferative Diabetic RetinopathyDiabetic Retinopathy+2 more Invirsa, Inc. 19
Testing effectiveness (Phase 2)Study completedNCT05383209What this trial is testingStudy of EYP-1901 in Patients With Nonproliferative Diabetic Retinopathy (NPDR)Who this might be right forNonproliferative Diabetic Retinopathy EyePoint Pharmaceuticals, Inc. 77
Not applicableUnknownNCT01759121What this trial is testingSafety and Effectiveness Study of 532nm Laser Subthreshold Panretinal Photocoagulation for Severe NPDRWho this might be right forSevere Non-proliferative Diabetic Retinopathy Sun Yat-sen University 84
Early research (Phase 1)Study completedNCT06487845What this trial is testingLearn How Safe BAY3283142 is When Taken as a Single Dose or as Multiple Doses in Healthy Chinese ParticipantsWho this might be right forChronic Kidney DiseaseNon-proliferative Diabetic RetinopathyHealthy Volunteers Bayer 24
Post-approval studies (Phase 4)Study completedNCT07230184What this trial is testingTo Evaluate the Efficacy and Safety of Combination Therapy With B55R1 and B55R2 Compared to B55R1 Monotherapy in Patients With NPDRWho this might be right forNon-Proliferative Diabetic Retinopathy AJU Pharm Co., Ltd. 52
Large-scale testing (Phase 3)Enrolling By InvitationNCT06951087What this trial is testingIntravitreal and Intracameral DEX in NPDRWho this might be right forNon-Proliferative Diabetic Retinopathy Affiliated Hospital of Nantong University 80
Large-scale testing (Phase 3)Ended earlyNCT05066230What this trial is testingEvaluate the Efficacy and Safety of Intravitreal KSI-301 in Non-proliferative Diabetic Retinopathy (NPDR)Who this might be right forNon-proliferative Diabetic Retinopathy Kodiak Sciences Inc 253
Testing effectiveness (Phase 2)Study completedNCT03197870What this trial is testingThe TIME-2b Study: A Study of AKB-9778 (Razuprotafib), a Novel Tie 2 Activator, in Patients With Non-Proliferative Diabetic Retinopathy (NPDR)Who this might be right forNonproliferative Diabetic Retinopathy EyePoint Pharmaceuticals, Inc. 167
Not applicableUnknownNCT03863535What this trial is testingPRP vs PRP+IVC for Severe nPDRWho this might be right forSevere Nonproliferative Diabetic RetinopathyDiabetic RetinopathyDiabete Mellitus Ruijin Hospital 40
Large-scale testing (Phase 3)Study completedNCT00131144What this trial is testingOctreotide Acetate in Microspheres in Patients With Diabetic RetinopathyWho this might be right forDiabetic Retinopathy Novartis 583
Large-scale testing (Phase 3)Ended earlyNCT00248157What this trial is testingExtension Study of the Long-term Safety and Tolerability of Octreotide Acetate in Patients With Moderately Severe or Severe Non-proliferative Diabetic Retinopathy or Low Risk Proliferative Diabetic RetinopathyWho this might be right forDiabetic Retinopathy Novartis Pharmaceuticals 105
Large-scale testing (Phase 3)Study completedNCT00130845What this trial is testingOctreotide Acetate in Microspheres in Patients With Diabetic RetinopathyWho this might be right forDiabetic Retinopathy Novartis 312
Not applicableLooking for participantsNCT06713720What this trial is testingRemote Ischemic Conditioning for Non-Proliferative Diabetic RetinopathyWho this might be right forDiabetic RetinopathyNon-Proliferative Diabetic RetinopathyRemote Ischemic Conditioning+2 more Xuxiang Zhang, MD 68